Bioregenx, Inc. v. Glycocheck US
2:25-cv-02071
Overview
Parties
Defendant
GENESIS HEALTH SCIENCES NPE (Individual / Inventor)
Represented By
0 Attorneys ListedGLYCOCALYX RESEARCH INSTITUTE NPE (Individual / Inventor)
Represented By
0 Attorneys ListedRNL LONEPEAK HOLDINGS, LLC NPE (Patent Assertion Entity)
Represented By
0 Attorneys ListedPlaintiff
Court & Judges
Court
District Court, D. Nevada (nvd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 3 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| π PCT International (WIPO) | PCT World Application | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7214666
Composition of orally administered nutritional supplements to repair articular cartilage
|
Filed: 2000-11-02
Issued: 2007-05-08
|
Expired (Term Ended)
+753d PTA
Expires: 2022-11-25
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
High PTA (+753 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
10
Dispositive
7
Granted
2
Denied
0
Pending / Review
7
Motions by Category
Key Dispositive Motions & Rulings